Biostatistical Challenges of Trials in Rare Diseases

April 26, 2018

Free Webinar on Biostatistical  Challenges of Trials in Rare Diseases

VIEW RECORDED WEBINAR
CONTENTS:

In this webinar:

  • We will start by briefly reviewing the European and international initiatives on rare diseases.
  • We will describe special statistical designs and analysis methodologies to address the problem of small populations. Innovative methodologies in the design and analysis of clinical trials in small population groups will be summarized focusing on results from the IDeAl project (IntegratedDEsign and AnaLysis of clinical trials in small population groups).
  • Ongoing efforts to bring the innovative methodology into practice and the next steps will be addressed in the conclusion.

Webinar on Biostatistical  Challenges of Trials in Rare Diseases

To access the presentation of this on-demand webinar, register to the right

ABSTRACT:
The definition of what is considered a rare disease differs all over the world. However, a common estimate is that the number of rare diseases currently amount to 6 to 8 thousand, with these disorders affecting almost 30 million people in Europe alone. Recent initiatives foster cross-border collaboration to bring new treatments faster to the patients, while recognizing the special demands of research on rare diseases. While clinical trials are a key component in drug development, research in rare diseases presents additional challenges compared with more common diseases.

SPEAKERS
Prof. Dr. Ralf-Dieter Hilgers Everardo Saad, MD
Professor in Biostatistics and chair of the Department of Medical Statistics, RWTH Aachen University, Germany Medical Director at the International Drug Development Institute (IDDI)
Rare diseases EVERARDO SAAD
Presentation of the Webinar Biostatistical Challenges of Trials in Rare Diseases

To access the presentation of this on-demand webinar, please fill out this form.

    By submitting this form, you agree to receiving commercial electronic messages such as e-mails from IDDI. For more info, please visit our Privacy Policy. You can unsubscribe at any time by clicking the 'unsubscribe' button at the foot of any e-mail communication from IDDI.

    I authorize IDDI to use my data to contact me for commercial purposes.More information